W
Wenhao Qin
Researcher at Second Military Medical University
Publications - 15
Citations - 401
Wenhao Qin is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 8, co-authored 14 publications receiving 233 citations.
Papers
More filters
Journal ArticleDOI
PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
Tao Luo,Jing Fu,An Xu,Bo Su,Yibing Ren,Ning Li,Junjie Zhu,Xiaofang Zhao,Rongyang Dai,Jie Cao,Bibo Wang,Wenhao Qin,Jinhua Jiang,Juan Li,Meng-Chao Wu,Gen-Sheng Feng,Yao Chen,Hongyang Wang +17 more
TL;DR: It is reported that PSMD10/gankyrin promotes autophagy in hepatocellular carcinoma (HCC) in response to starvation or stress through 2 complementary routes, and this results present a novel mechanism involving modulation of ATG7 by PS MD10 in sustainingAutophagy, promoting HCC cell survival against starvation or chemotherapy.
Journal ArticleDOI
High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
Wenhao Qin,Zhishi Yang,Mian Li,Yao Chen,Xiaofang Zhao,Ying-Yi Qin,Jia-Qi Song,Bibo Wang,Bo Yuan,Xiuliang Cui,Feng Shen,Jia He,Yufang Bi,Guang Ning,Jing Fu,Jing Fu,Hongyang Wang,Hongyang Wang +17 more
TL;DR: Cholesterol to accumulate in NK cells and activate their effector functions against hepatoma cells against liver tumors in mice with homozygous disruption of ApoE, found.
Journal ArticleDOI
Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts.
Zhishi Yang,Wenhao Qin,Yao Chen,Bo Yuan,Xiaoling Song,Bibo Wang,Feng Shen,Jing Fu,Jing Fu,Hongyang Wang +9 more
TL;DR: It is reported that high levels of cholesterol predict good survival and low disease recurrence after surgery and pharmacologically promoting CD44 retention inside lipid rafts obviously attenuated HCC migration and invasion, providing a potential therapeutic strategy to prolong the survival of HCC patients.
Journal ArticleDOI
ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.
Xiaofang Zhao,Xiaofang Zhao,Wenhao Qin,Youhai Jiang,Youhai Jiang,Zhishi Yang,Bo Yuan,Rongyang Dai,Hao Shen,Yao Chen,Jing Fu,Jing Fu,Hongyang Wang,Hongyang Wang,Hongyang Wang +14 more
TL;DR: It is found that ACADL was frequently downregulated in hepatocellular carcinoma (HCC), and its low expression was significantly correlated with poor clinical prognosis of HCC patients and targeting ACadL/Yap may be a potential strategy for HCC precise treatment.
Journal ArticleDOI
Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes
Geoffrey J. Markowitz,Pengyuan Yang,Jing Fu,Gregory A. Michelotti,Rui Chen,Jianhua Sui,Bin Yang,Wenhao Qin,Zheng Zhang,Fu-Sheng Wang,Anna Mae Diehl,Qi-Jing Li,Hongyang Wang,Xiao-Fan Wang +13 more
TL;DR: It is found that IL18 exerted inflammation-dependent tumor-suppressive effects largely by promoting the differentiation, activity, and survival of tumor-infiltrating T cells and differences in the expression of IL18 in tumor tissue versus nontumors were more predictive of patient outcome than overall tissue expression.